Literature DB >> 15624099

C-peptide stimulates ERK1/2 and JNK MAP kinases via activation of protein kinase C in human renal tubular cells.

Z Zhong1, A Davidescu, I Ehrén, K Ekberg, H Jörnvall, J Wahren, A V Chibalin.   

Abstract

AIMS/HYPOTHESIS: Accumulating evidence indicates that replacement of C-peptide in type 1 diabetes ameliorates nerve and kidney dysfunction, but the molecular mechanisms involved are incompletely understood. C-peptide shows specific binding to a G-protein-coupled membrane binding site, resulting in Ca(2+) influx, activation of mitogen-activated protein kinase signalling pathways, and stimulation of Na(+), K(+)-ATPase and endothelial nitric oxide synthase. This study examines the intracellular signalling pathways activated by C-peptide in human renal tubular cells.
METHODS: Human renal tubular cells were cultured from the outer cortex of renal tissue obtained from patients undergoing elective nephrectomy. Extracellular-signal-regulated kinase 1/2 (ERK1/2), c-Jun N-terminal kinase (JNK) and Akt/protein kinase B (PKB) activation was determined using phospho-specific antibodies. Protein kinase C (PKC) and RhoA activation was determined by measuring their translocation to the cell membrane fraction using isoform-specific antibodies.
RESULTS: Human C-peptide increases phosphorylation of ERK1/2 and Akt/PKB in a concentration- and time-dependent manner in renal tubular cells. The C-terminal pentapeptide of C-peptide is equipotent with the full-length C-peptide, whereas scrambled C-peptide has no effect. C-peptide stimulation also results in phosphorylation of JNK, but not of p38 mitogen-activated protein kinase. MEK1/2 inhibitor PD98059 blocks the C-peptide effect on ERK1/2 phosphorylation. C-peptide causes specific translocation of PKC isoforms delta and epsilon to the membrane fraction in tubular cells. All stimulatory effects of C-peptide were abolished by pertussis toxin. The isoform-specific PKC-delta inhibitor rottlerin and the broad-spectrum PKC inhibitor GF109203X both abolish the C-peptide effect on ERK1/2 phosphorylation. C-peptide stimulation also causes translocation of the small GTPase RhoA from the cytosol to the cell membrane. Inhibition of phospholipase C abolished the stimulatory effect of C-peptide on phosphorylation of ERK1/2, JNK and PKC-delta. CONCLUSIONS/
INTERPRETATION: C-peptide signal transduction in human renal tubular cells involves the activation of phospholipase C and PKC-delta and PKC-epsilon, as well as RhoA, followed by phosphorylation of ERK1/2 and JNK, and a parallel activation of Akt.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15624099     DOI: 10.1007/s00125-004-1602-5

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  46 in total

Review 1.  Regulation of cardiac L-type calcium channels by protein kinase A and protein kinase C.

Authors:  T J Kamp; J W Hell
Journal:  Circ Res       Date:  2000-12-08       Impact factor: 17.367

Review 2.  Regulation of cardiac and smooth muscle Ca(2+) channels (Ca(V)1.2a,b) by protein kinases.

Authors:  K D Keef; J R Hume; J Zhong
Journal:  Am J Physiol Cell Physiol       Date:  2001-12       Impact factor: 4.249

3.  Potent activation of multiple signalling pathways by C-peptide in opossum kidney proximal tubular cells.

Authors:  N M Al-Rasheed; F Meakin; E L Royal; A J Lewington; J Brown; G B Willars; N J Brunskill
Journal:  Diabetologia       Date:  2004-05-26       Impact factor: 10.122

4.  Prevention of vascular and neural dysfunction in diabetic rats by C-peptide.

Authors:  Y Ido; A Vindigni; K Chang; L Stramm; R Chance; W F Heath; R D DiMarchi; E Di Cera; J R Williamson
Journal:  Science       Date:  1997-07-25       Impact factor: 47.728

5.  Diabetes decreases Na+-K+ pump concentration in skeletal muscles, heart ventricular muscle, and peripheral nerves of rat.

Authors:  K Kjeldsen; H Braendgaard; P Sidenius; J S Larsen; A Nørgaard
Journal:  Diabetes       Date:  1987-07       Impact factor: 9.461

6.  Effects of C-peptide on glomerular and renal size and renal function in diabetic rats.

Authors:  B Samnegård; S H Jacobson; G Jaremko; B L Johansson; M Sjöquist
Journal:  Kidney Int       Date:  2001-10       Impact factor: 10.612

7.  Molecular evidence for pap-G specific adhesion of Escherichia coli to human renal cells.

Authors:  M Söderhäll; U S Bergerheim; S H Jacobson; J Lundahl; R Möllby; S Normark; J Winberg
Journal:  J Urol       Date:  1997-01       Impact factor: 7.450

8.  C-peptide increases forearm blood flow in patients with type 1 diabetes via a nitric oxide-dependent mechanism.

Authors:  Bo-Lennart Johansson; John Wahren; John Pernow
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-06-10       Impact factor: 4.310

9.  Cloning and characterization of a G protein-activated human phosphoinositide-3 kinase.

Authors:  B Stoyanov; S Volinia; T Hanck; I Rubio; M Loubtchenkov; D Malek; S Stoyanova; B Vanhaesebroeck; R Dhand; B Nürnberg
Journal:  Science       Date:  1995-08-04       Impact factor: 47.728

10.  Proinsulin C-peptide replacement in type 1 diabetic BB/Wor-rats prevents deficits in nerve fiber regeneration.

Authors:  Christopher R Pierson; Weixian Zhang; Anders A F Sima
Journal:  J Neuropathol Exp Neurol       Date:  2003-07       Impact factor: 3.685

View more
  23 in total

1.  (Na+ + K+)-ATPase is a target for phosphoinositide 3-kinase/protein kinase B and protein kinase C pathways triggered by albumin.

Authors:  Diogo B Peruchetti; Ana Acacia S Pinheiro; Sharon S Landgraf; Mira Wengert; Christina M Takiya; William B Guggino; Celso Caruso-Neves
Journal:  J Biol Chem       Date:  2011-11-04       Impact factor: 5.157

2.  C-peptide is a bioactive peptide.

Authors:  J Wahren; K Ekberg; H Jörnvall
Journal:  Diabetologia       Date:  2007-01-18       Impact factor: 10.122

3.  Fibroblast growth factor 1 ameliorates diabetic nephropathy by an anti-inflammatory mechanism.

Authors:  Guang Liang; Lintao Song; Zilu Chen; Yuanyuan Qian; Junjun Xie; Longwei Zhao; Qian Lin; Guanghui Zhu; Yi Tan; Xiaokun Li; Moosa Mohammadi; Zhifeng Huang
Journal:  Kidney Int       Date:  2017-07-24       Impact factor: 10.612

Review 4.  Insights into the physiology of C-peptide.

Authors:  D Vejrazkova; M Vankova; P Lukasova; J Vcelak; B Bendlova
Journal:  Physiol Res       Date:  2020-09-30       Impact factor: 1.881

5.  Proinsulin C-peptide elicits disaggregation of insulin resulting in enhanced physiological insulin effects.

Authors:  J Shafqat; E Melles; K Sigmundsson; B-L Johansson; K Ekberg; G Alvelius; M Henriksson; J Johansson; J Wahren; H Jörnvall
Journal:  Cell Mol Life Sci       Date:  2006-08       Impact factor: 9.261

Review 6.  Physiological effects and therapeutic potential of proinsulin C-peptide.

Authors:  Gina L C Yosten; Christine Maric-Bilkan; Patrizia Luppi; John Wahren
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-09-23       Impact factor: 4.310

7.  C-Peptide and its intracellular signaling.

Authors:  Claire E Hills; Nigel J Brunskill
Journal:  Rev Diabet Stud       Date:  2009-11-10

8.  Molecular effects of C-Peptide in microvascular blood flow regulation.

Authors:  Thomas Forst; Thomas Hach; Thomas Kunt; Matthias M Weber; Andreas Pfützner
Journal:  Rev Diabet Stud       Date:  2009-11-10

Review 9.  Proinsulin C-peptide: friend or foe in the development of diabetes-associated complications?

Authors:  Lina Nordquist; M Johansson
Journal:  Vasc Health Risk Manag       Date:  2008

10.  Renal and vascular benefits of C-peptide: Molecular mechanisms of C-peptide action.

Authors:  Lina Nordquist; Fredrik Palm; Bradley T Andresen
Journal:  Biologics       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.